Array
In a groundbreaking collaboration, BASF, a global leader in chemical manufacturing, has partnered with Sinclair The New Generation Paints to launch the Philippines’ first antimicrobial paint, Dr. Paint. It is poised to revolutionize the local paint industry by offering advanced protection against viruses and bacteria, setting a new standard for safety and performance.
A New Era of Paint Technology
Dr. Paint results from Sinclair’s commitment to innovation and expertise in cutting-edge chemical solutions. This pioneering antimicrobial paint goes beyond the traditional expectations of paint, offering color and an active defense against harmful microorganisms on wall surfaces. Tested carefully, Dr. Paint has shown efficacy in denaturing a wide range of viruses and bacteria, making it an essential choice for homes, offices, and public spaces.
“With Dr. Paint, we’re not just adding color to walls; we’re adding a layer of protection,” said inventor and innovator Derrick Tan, MPCTI President and CEO. “This partnership with BASF allows us to bring a product to the market that aligns with our vision of combining aesthetics with advanced functionality.”
Advanced Protection for a Safer Environment
Dr. Paint’s antimicrobial properties are designed to combat prevalent viruses and bacteria, including COVID-19 with 99.41% efficacy, Influenza Virus A with 99.93% efficacy, and Hand-Foot-and-Mouth Disease with a 99.11% efficacy rate. It is also APEO-free, ensuring the paint is safe for individuals with sensitive skin, and providing peace of mind for families and businesses concerned about health and hygiene.
Innovative Features: Beyond Just Paint
In addition to its antimicrobial benefits, Dr. Paint embodies Sinclair’s philosophy of merging aesthetics with functionality. The paint is designed to meet the highest standards of durability and ease of application, offering vibrant colors with long-lasting performance.
